You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Best Practices in Selecting a Disease-Modifying Therapy in Multiple Sclerosis: COVID-19 as an Emerging Consideration

  • Authors: Anne H. Cross, MD; Thomas P. Leist, MD, PhD; Jiwon Oh, MD, PhD
  • CME / ABIM MOC Released: 5/16/2022
  • Valid for credit through: 5/16/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for neurologists, nurse practitioners, and physician assistants.

The goal of this activity is that learners will have increased awareness of the factors involved in selecting disease-modifying therapies (DMTs), and particularly the emerging role that COVID-19 may have on treatment decisions for patients with multiple sclerosis.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Consideration of factors involved in the selection of DMTs for the treatment of MS
    • Recommendations for the selection of DMTs for patients with MS based on COVID-19 status


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Anne H. Cross, MD

    Professor of Neurology and Head of the Neuroimmunology Section
    The Manny and Rosalyn Rosenthal-Dr John L. Trotter MS Center Chair in Neuroimmunology
    Department of Neurology
    Washington University School of Medicine
    St Louis, Missouri

    Disclosures

    Disclosure: Anne H. Cross, MD, has the following relevant financial relationships: the following relevant financial relationships:
    Consultant or advisor for: Biogen; EMD Serono/Merck; Bristol Myers Squibb Company; Genentech/Roche; Greenwich Biosciences; Horizon Pharma; Janssen; Novartis; TG Therapeutics, Inc.
    Contracted researcher for: EMD Serono/Genentech

  • Thomas P. Leist, MD, PhD

    Professor of Neurology
    Chief
    Division of Clinical Neuroimmunology
    Director
    Comprehensive Multiple Sclerosis Center
    Thomas Jefferson University
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Thomas P. Leist, MD, PhD, has the following relevant financial relationships: the following relevant financial relationships:
    Consultant or advisor for: Biogen; Horizon Pharma; Genentech; Janssen; Novartis; Sanofi
    Speaker or member of speakers bureau for: Alexion Pharmaceuticals, Inc.; Biogen; Genentech; Horizon Pharma
    Contracted researcher for: Biogen; Genentech; Horizon Pharma; Janssen; Novartis; Sanofi

  • Jiwon Oh, MD, PhD

    Associate Professor
    Medical Director
    Barlo Multiple Sclerosis (MS) Program
    St Michael’s Hospital, University of Toronto
    Toronto, Ontario, Canada

    Disclosures

    Disclosure: Jiwon Oh, MD, PhD, has the following relevant financial relationships: the following relevant financial relationships:
    Consultant or advisor for: Biogen-Idec; Bristol Myers Squibb Company; EMD-Serono; Novartis; Roche; Sanofi-Genzyme
    Speaker or member of speakers bureau for: Biogen-Idec; EMD-Serono; Roche; Sanofi-Genzyme
    Research funding from: Biogen-Idec; EMD-Serono; Roche

Health Care Perspective

  • Patricia Melville, MSN, ANP-BC, MSCN

    Clinical Instructor
    Stony Brook University Medical Center
    Stony Brook, NY

    Disclosures

    Disclosure: Patricia Melville, MSN, ANP-BC, MSCN, has the following relevant financial relationships: the following relevant financial relationships:
    Consultant or advisor for: Alexion; Biogen; Bristol Myers Squibb Company; EMD-Serono; Genentech; Horizon
    Speaker or member of speakers bureau for: Alexion; Biogen; Bristol Myers Squibb Company; EMD-Serono; Genentech; Horizon
    Research funding from: Bristol Myers Squibb Company; CorEvitas; Genentech; Point of Care; Sanofi-Genzyme

Editors

  • Lisette Arnaud-Hevi, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Lisette Arnaud-Hevi, PhD, has no relevant financial relationships.

  • Megan Breuer, PhD

    Medical Writer, Medscape, LLC

    Disclosures

    Disclosure: Megan Breuer, PhD, has the following relevant financial relationship: Consultant/advisor Paratek Pharmaceuticals, Inc. (former)

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Best Practices in Selecting a Disease-Modifying Therapy in Multiple Sclerosis: COVID-19 as an Emerging Consideration

Authors: Anne H. Cross, MD; Thomas P. Leist, MD, PhD; Jiwon Oh, MD, PhDFaculty and Disclosures

CME / ABIM MOC Released: 5/16/2022

Valid for credit through: 5/16/2023

processing....

Note: The information on the COVID-19 outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to the approved COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer. 

 

 

  • Print